BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12733253)

  • 1. [Local complications in the skin related to the administration of insulin].
    Camata DG
    Rev Lat Am Enfermagem; 2003; 11(1):119-22. PubMed ID: 12733253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemir.
    O'goshi K; Serup J; Blaaholm B; Thomsen HK; Rossing P; Tarnow L
    Skin Res Technol; 2011 Nov; 17(4):411-9. PubMed ID: 21729174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulomatous dermatitis caused by surfen in diabetics treated with Insulin-depot-S-Richter].
    Jermendy G; Szabó E
    Orv Hetil; 1989 Aug; 130(34):1825-8. PubMed ID: 2528707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus.
    Winkler G; Sápi Z; Pál B; Molnár L
    Diabet Med; 1997 Dec; 14(12):1078-9. PubMed ID: 9455937
    [No Abstract]   [Full Text] [Related]  

  • 5. [Skin reaction following cutaneous insulin injection in diabetic patients requiring insulin].
    Heller H
    Allerg Asthma (Leipz); 1970; 16(4):161-7. PubMed ID: 4257714
    [No Abstract]   [Full Text] [Related]  

  • 6. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive insulin therapy].
    Landgraf R; Huber RM; Bachmann A; Lohr R
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoglycemia in type 2 diabetes.
    Banarer S; Cryer PE
    Med Clin North Am; 2004 Jul; 88(4):1107-16, xii-xiii. PubMed ID: 15308392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin treatment of type 1 diabetes in adults].
    Birkeland KI
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):776-8. PubMed ID: 16541173
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic effect of hypoglycemia in a health plan.
    Heaton A; Martin S; Brelje T
    Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninjectable methods of insulin administration.
    Cernea S; Raz I
    Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insuline glusine (Apidra): a new rapid-acting insulin.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.
    Yang W; Ji Q; Zhu D; Yang J; Chen L; Liu Z; Yu D; Yan L
    Diabetes Care; 2008 May; 31(5):852-6. PubMed ID: 18268073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.